key: cord-0957130-s0ak2gm7
authors: Azzi, Yorg; Raees, Harith; Wang, Tao; Cleare, Levi; Liriano-Ward, Luz; Loarte-Campos, Pablo; Pynadath, Cindy; Ajaimy, Maria; Alani, Omar; Bao, Yi; Pirofski, Liise-anne; Akalin, Enver
title: Risks factors associated with poor response to COVID-19 vaccination in kidney transplant recipients
date: 2021-09-03
journal: Kidney Int
DOI: 10.1016/j.kint.2021.08.019
sha: 166ad81ffc1a2011ca13b5d634086f925e885fb0
doc_id: 957130
cord_uid: s0ak2gm7

nan

The case fatality ratio of COVID-19 in kidney transplant recipients (KTR) is between 10-30% 1,2 , underscoring the importance of vaccination to prevent COVID-19. However, KTR have a reduced response to COVID-19 vaccines (18%-54%) 3, 4 . We determined SARS-CoV-2 spike IgG (Table) . Sixty-five% of those with CD4 counts > 400 and 57% with CD3 counts > 1,000 responded, but only 17% and 13%, respectively, of with CD4 counts < 400 and CD3 counts < 500 responded (Supplemental Figure 1 A and 1B) . In summary, lack of response to COVID-19 vaccines was associated with African American race, being on high dose anti-metabolite therapy, and having lower pre-vaccination CD3, CD4 T cell and serum IgM levels.

Supplemental Figure 

COVID-19 infection in kidney transplant recipients at the epicenter of pandemics

COVID-19 and Solid Organ Transplantation: A Review Article

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients